Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-26 @ 1:03 AM
Study NCT ID:
NCT03499834
Status:
COMPLETED
Last Update Posted:
2020-04-16
First Post:
2018-04-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy
Sponsor:
Ivy Life Sciences, Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-02
First Submit QC Date:
None
Study First Post Date:
2018-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-14
Last Update Post Date:
2020-04-16
Last Update Post Date Type:
ACTUAL